Xometry, Inc. (NASDAQ:XMTR – Get Free Report) COO Peter Goguen sold 12,000 shares of the firm’s stock in a transaction dated Thursday, November 7th. The stock was sold at an average price of $29.55, for a total value of $354,600.00. Following the completion of the transaction, the chief operating officer now owns 180,419 shares in the company, valued at approximately $5,331,381.45. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Peter Goguen also recently made the following trade(s):
- On Monday, November 11th, Peter Goguen sold 5,000 shares of Xometry stock. The shares were sold at an average price of $32.00, for a total value of $160,000.00.
- On Thursday, October 3rd, Peter Goguen sold 940 shares of Xometry stock. The stock was sold at an average price of $17.22, for a total value of $16,186.80.
Xometry Stock Down 2.6 %
Shares of NASDAQ XMTR traded down $0.84 during mid-day trading on Tuesday, reaching $31.34. The company had a trading volume of 347,740 shares, compared to its average volume of 605,142. The company has a debt-to-equity ratio of 0.90, a quick ratio of 4.60 and a current ratio of 4.59. Xometry, Inc. has a twelve month low of $11.08 and a twelve month high of $38.74. The stock’s 50 day moving average is $20.02 and its 200-day moving average is $16.95. The stock has a market capitalization of $1.54 billion, a PE ratio of -30.10 and a beta of 0.55.
Institutional Trading of Xometry
Analyst Ratings Changes
Several brokerages have recently issued reports on XMTR. Cantor Fitzgerald reiterated an “underweight” rating and set a $12.00 price target on shares of Xometry in a report on Wednesday, November 6th. Royal Bank of Canada increased their price objective on shares of Xometry from $23.00 to $27.00 and gave the company a “sector perform” rating in a research report on Wednesday, November 6th. Craig Hallum lifted their price objective on shares of Xometry from $20.00 to $30.00 and gave the stock a “buy” rating in a research note on Wednesday, November 6th. Citigroup boosted their target price on shares of Xometry from $25.00 to $33.00 and gave the stock a “buy” rating in a research report on Wednesday, November 6th. Finally, The Goldman Sachs Group upped their target price on shares of Xometry from $24.00 to $28.00 and gave the stock a “buy” rating in a report on Wednesday, November 6th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $26.29.
Check Out Our Latest Stock Analysis on XMTR
About Xometry
Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.
See Also
- Five stocks we like better than Xometry
- CD Calculator: Certificate of Deposit Calculator
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- What is Forex and How Does it Work?
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- 3 REITs to Buy and Hold for the Long Term
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Receive News & Ratings for Xometry Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xometry and related companies with MarketBeat.com's FREE daily email newsletter.